Maglasang, Rex Harold R.

HRN: 21-36-24  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/13/2025
CEFTRIAXONE 1G (VIAL)
04/13/2025
04/20/2025
IV
2G
OD
For Herniorrhaphy
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: